-
1
-
-
0029804807
-
Dihydroorotate dehydrogenase is a target for the biological effects of leflunomide
-
Williamson RA, Yea CM, Robson PA, Curnock AP, Gadher S, Hambleton AB, et al. Dihydroorotate dehydrogenase is a target for the biological effects of leflunomide. Transplant Proc 1996;28:3088-91.
-
(1996)
Transplant Proc
, vol.28
, pp. 3088-3091
-
-
Williamson, R.A.1
Yea, C.M.2
Robson, P.A.3
Curnock, A.P.4
Gadher, S.5
Hambleton, A.B.6
-
2
-
-
1542377415
-
Japan deaths spark concerns over arthritis drug
-
McCurry J. Japan deaths spark concerns over arthritis drug. Lancet 2004;363:461.
-
(2004)
Lancet
, vol.363
, pp. 461
-
-
McCurry, J.1
-
3
-
-
0029964158
-
A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage
-
Linke SP, Clarkin KC, di Leonardo A, Tsou A, Wahl GM. A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes Dev 1996;10:934-47.
-
(1996)
Genes Dev
, vol.10
, pp. 934-947
-
-
Linke, S.P.1
Clarkin, K.C.2
Di Leonardo, A.3
Tsou, A.4
Wahl, G.M.5
-
4
-
-
0030987746
-
Leflunomide and malononitr-Hamides
-
Silva HT, Morris RE. Leflunomide and malononitr-Hamides. Am J Med Sci 1997;313:289-301.
-
(1997)
Am J Med Sci
, vol.313
, pp. 289-301
-
-
Silva, H.T.1
Morris, R.E.2
-
5
-
-
19044362988
-
Arthritis drug should be removed from market, says consumer group
-
Charatan F. Arthritis drug should be removed from market, says consumer group. BMJ 2002;324:869.
-
(2002)
BMJ
, vol.324
, pp. 869
-
-
Charatan, F.1
-
6
-
-
0031838192
-
Clinical experience with leflunomide in rheumatoid arthritis
-
Rozman B. Clinical experience with leflunomide in rheumatoid arthritis. J Rheumatol Suppl 1998;53:27-32.
-
(1998)
J Rheumatol Suppl
, vol.53
, pp. 27-32
-
-
Rozman, B.1
-
7
-
-
0033596065
-
Treatment of active rheumatoid arthritis with leflunomide compared to placebo and methotrexate
-
Strand V, Cohen S, Schiff M, Weaver A, Fleischmann R, Cannon G, et al. Treatment of active rheumatoid arthritis with leflunomide compared to placebo and methotrexate. Arch Intern Med 1999;159:2542-50.
-
(1999)
Arch Intern Med
, vol.159
, pp. 2542-2550
-
-
Strand, V.1
Cohen, S.2
Schiff, M.3
Weaver, A.4
Fleischmann, R.5
Cannon, G.6
-
8
-
-
0033053835
-
Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: A double-blinded, randomised, multicenter trial
-
Smolen JS, Kalden JR, Scott DL, Rozman B, Kvien TK, Larsen A, et al. Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blinded, randomised, multicenter trial. Lancet 1999;353:259-66.
-
(1999)
Lancet
, vol.353
, pp. 259-266
-
-
Smolen, J.S.1
Kalden, J.R.2
Scott, D.L.3
Rozman, B.4
Kvien, T.K.5
Larsen, A.6
-
9
-
-
0013416058
-
Leflunomide: Serious hepatic, blood, skin and respiratory reactions
-
Adverse Drug Reactions Advisory Committee (ADRAC). Leflunomide: serious hepatic, blood, skin and respiratory reactions. Aust Adv Drug React Bull 2001;20:7.
-
(2001)
Aust Adv Drug React Bull
, vol.20
, pp. 7
-
-
-
10
-
-
3042559297
-
Leflunomide(Arava): Hematologic, hepatic and respiratory reactions
-
Lili LS, Mano M. Leflunomide(Arava): hematologic, hepatic and respiratory reactions. Can Adv React Newsletter 2002;12:2-3.
-
(2002)
Can Adv React Newsletter
, vol.12
, pp. 2-3
-
-
Lili, L.S.1
Mano, M.2
-
11
-
-
0027978191
-
Bronchiectasis: A late feature of severe rheumatoid arthritis
-
Shadick NA, Fanta CH, Weinblatt M, O'Donnell W, Coblyn JS. Bronchiectasis: a late feature of severe rheumatoid arthritis. Medicine 1994;73:161-70.
-
(1994)
Medicine
, vol.73
, pp. 161-170
-
-
Shadick, N.A.1
Fanta, C.H.2
Weinblatt, M.3
O'Donnell, W.4
Coblyn, J.S.5
-
12
-
-
9444258929
-
A case of methotrexate-associated interstitial pneumonitis in rheumatoid arthritis
-
Kim JY, Kim WU, Kim SI, Yoo WH, Park SH, Hong YS, et al. A case of methotrexate-associated interstitial pneumonitis in rheumatoid arthritis. J Korean Rheum Assoc 1998;5:126-32.
-
(1998)
J Korean Rheum Assoc
, vol.5
, pp. 126-132
-
-
Kim, J.Y.1
Kim, W.U.2
Kim, S.I.3
Yoo, W.H.4
Park, S.H.5
Hong, Y.S.6
-
13
-
-
0033964302
-
Msthotrexate pneumonitis: Review of the literature and histopathological findings in nine patients
-
Imokawa S, Colby TV, Lesilie KO, Helmers RA, Msthotrexate pneumonitis: review of the literature and histopathological findings in nine patients. Eur Respir J 2000;15:373-81.
-
(2000)
Eur Respir J
, vol.15
, pp. 373-381
-
-
Imokawa, S.1
Colby, T.V.2
Lesilie, K.O.3
Helmers, R.A.4
-
14
-
-
2342454966
-
A case of hypersensitivity pneumonitis caused by methotrexate
-
Suh HJ, Park EH, Chuug MP, Shin SC, Jeon KM, Yu CM, et al. A case of hypersensitivity pneumonitis caused by methotrexate. Tuberc Respir Dis 2004;56:203-9.
-
(2004)
Tuberc Respir Dis
, vol.56
, pp. 203-209
-
-
Suh, H.J.1
Park, E.H.2
Chuug, M.P.3
Shin, S.C.4
Jeon, K.M.5
Yu, C.M.6
|